Rohto Pharmaceutical Co Ltd represents a set of values and corporate philosophy that focuses on improving people's lives through innovative healthcare products. The company is committed to providing safe, effective, and high-quality solutions to meet various medical and beauty needs. Rohto Pharmaceutical Co Ltd believes in continuous research and development, ensuring that their products are backed by scientific expertise. With a strong emphasis on customer satisfaction, the company aims to contribute to society by promoting better health and well-being. Rohto Pharmaceutical Co Ltd's dedication to excellence and its mission to enhance the lives of individuals make it a trusted name in the pharmaceutical industry.

Rohto Pharmaceutical Co Ltd is primarily present in Japan, its home country. As a leading pharmaceutical company, Rohto has established its presence and reputation domestically. With a strong focus on developing and marketing innovative healthcare products, Rohto has gained a significant market share in Japan. The company's commitment to providing high-quality healthcare solutions has made it a trusted brand among consumers in the region. Rohto continues to expand its operations and aims to bring its products to other countries and regions in the future.

Rohto Pharmaceutical Co Ltd, a renowned company in the pharmaceutical industry, has achieved several significant milestones. The company has successfully expanded its global presence through strategic partnerships and acquisitions, strengthening its position in the market. Rohto Pharmaceutical Co Ltd has also developed innovative and high-quality healthcare products, addressing various medical needs. With a focus on research and development, the company has made breakthroughs in the pharmaceutical sector, contributing to advancements in healthcare. Moreover, Rohto Pharmaceutical Co Ltd has gained recognition for its commitment to ensuring the well-being and satisfaction of its customers worldwide.

Rohto Pharmaceutical Co Ltd, founded in 1899, is a well-established Japanese healthcare company. With a rich history spanning over a century, the company has garnered a reputation for manufacturing and distributing innovative pharmaceutical products globally. Rohto Pharmaceutical specializes in developing healthcare solutions across various domains, including skincare, eye care, oral care, and pain relief. With a strong commitment to research and development, the company consistently delivers high-quality, reliable products that cater to diverse consumer needs. Over the years, Rohto Pharmaceutical has become synonymous with excellence in the healthcare industry, consistently striving to improve the overall well-being and health of individuals worldwide.

The main competitors of Rohto Pharmaceutical Co Ltd in the market include Johnson & Johnson, Pfizer Inc., Novartis International AG, and GlaxoSmithKline plc.

Rohto Pharmaceutical Co Ltd is primarily active in the healthcare and personal care industries.

The business model of Rohto Pharmaceutical Co Ltd revolves around developing, manufacturing, and marketing a wide range of innovative healthcare products. Rohto Pharmaceutical aims to contribute to the well-being of individuals by providing high-quality medicines, cosmetics, and functional foods. As a leading Japanese company in the pharmaceutical industry, Rohto Pharmaceutical focuses on research and development to create breakthrough solutions for various health concerns. With a strong commitment to improving people's lives, Rohto Pharmaceutical continues to expand its product portfolio while ensuring adherence to strict quality standards.

Rohto Pharmaceutical Co에 대한 현재 주가 수익 비율을 계산할 수 없습니다.

Rohto Pharmaceutical Co에 대한 현재 KUV는 계산할 수 없습니다.

Rohto Pharmaceutical Co에 대한 AlleAktien 품질 점수는 9/10입니다.

Rohto Pharmaceutical Co에 대한 현재 매출은 계산할 수 없습니다.

Rohto Pharmaceutical Co의 현재 이익을 계산할 수 없습니다.

Rohto Pharmaceutical Co Ltd is a Japanese company specializing in the manufacturing and sale of healthcare products. It was founded in 1899 and has its headquarters in Osaka, Japan. It is part of the Rohto-Mentholatum group and operates worldwide. The company's main divisions are ophthalmic, dermatological, and oral care products. In the ophthalmic division, Rohto Pharmaceutical holds a leading position in the Japanese market, offering eye drops, lens care products, and eye washes for both medical and cosmetic purposes. In dermatology, the company provides various skin creams, pain ointments, and lip balms to help with skin issues such as acne, eczema, psoriasis, and other irritations. Their oral care products include toothpaste, mouthwash, and gum. Rohto Pharmaceutical also offers a range of pain relievers for headaches, backaches, muscle pains, and menstrual discomfort, marketed under brand names such as "Zanidip" and "Sai-Ro." With a strong presence in the Asian market, Rohto Pharmaceutical continues to expand into North America and Europe. It has subsidiaries in China, Hong Kong, Taiwan, and Thailand, as well as branches in North America and Europe. The company has partnerships with local businesses in various countries and operates joint ventures to expand its global presence. Rohto Pharmaceutical's business model relies on innovation and quality control. It invests in research and development to develop new products and improve existing ones. The company also implements rigorous controls in all its production facilities to ensure its products meet the highest quality standards. Rohto Pharmaceutical holds multiple patents for its products and technologies. The company is known for its marketing strategies, prioritizing brand awareness and utilizing various media to promote its products. It also maintains a presence on social media and employs online marketing to sell its products. Rohto Pharmaceutical is expected to continue expanding and entering new markets. With a strong position in the Asian market, it is likely to focus on expanding in North America and Europe. Continued investment in research and development and the introduction of new products are also expected to drive the company's growth. Overall, the future of Rohto Pharmaceutical is promising, and it is expected to remain a significant player in the healthcare industry.

Rohto Pharmaceutical Co은(는) 연간 2번의 배당을 통해 0 JPY의 배당금을 지급합니다.

Rohto Pharmaceutical Co는 연간 2번의 배당금을 지급합니다.

Rohto Pharmaceutical Co의 ISIN은 JP3982400008입니다.

Rohto Pharmaceutical Co의 WKN은 858075입니다.

Rohto Pharmaceutical Co의 티커는 4527.T입니다.

지난 12개월 동안 Rohto Pharmaceutical Co은(는) 의 배당금을 지급했습니다. 이는 약 의 배당 수익률에 해당합니다. 향후 12개월 동안 Rohto Pharmaceutical Co은(는) 33.11 JPY의 배당금을 지급할 것으로 예상됩니다.

Rohto Pharmaceutical Co의 현재 배당 수익률은 입니다.

Rohto Pharmaceutical Co은 분기별로 배당금을 지급합니다. 이는 , , , 월에 배당됩니다.

Rohto Pharmaceutical Co은(는) 지난 23년 동안 매년 배당금을 지급했습니다.

향후 12개월 동안 33.11 JPY의 배당금이 예상됩니다. 이는 배당수익률 1.13 %에 해당합니다.

Rohto Pharmaceutical Co은 '비사이클 소비' 섹터에 속합니다.

Rohto Pharmaceutical Co의 마지막 배당금을 16 JPY만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

마지막 배당금 지급일은 입니다.

2023년에 Rohto Pharmaceutical Co는 24 JPY를 배당금으로 지급했습니다.

Rohto Pharmaceutical Co의 배당금은 JPY에 지급됩니다.